| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534788 Benzofuran and benzothiophene-2-carboxylic acid amide derivatives |
| 05/19/2009 | CA2611072A1 Novel compounds and uses thereof |
| 05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/19/2009 | CA2320921C Optically active tris(2,3-epoxypropyl)isocyanurates |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2009060779A1 Organic electroluminescent device material, organic electroluminescent device, display device and illuminating device |
| 05/14/2009 | WO2009060757A1 Organic electroluminescent device, display device and illuminating device |
| 05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
| 05/14/2009 | WO2009059783A1 Stereo-specific hydroxylation |
| 05/14/2009 | WO2009031040A3 Compounds with anti-cancer activity |
| 05/14/2009 | WO2009019561A3 Process for preparing chiral compounds |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | US20090124680 Use of prodrug composition containing naphthoquinone-based compound for manufacture of medicament for treatment or prevention of diseases involving metabolic syndrome |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124646 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 05/14/2009 | US20090124635 Chemical compounds |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
| 05/14/2009 | US20090124613 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/13/2009 | EP2057149A2 Pseudobase benzo [c]phenanthridines with improved efficacy, stability, and safety |
| 05/13/2009 | EP2057148A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 05/13/2009 | EP2057146A1 Compounds and compositions as protein kinase inhibitors |
| 05/13/2009 | EP2057143A2 5-substituted isoindoline compounds |
| 05/13/2009 | EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors |
| 05/13/2009 | EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 05/13/2009 | EP2057138A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 05/13/2009 | EP1711485B1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 05/13/2009 | EP1377570B1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432279A N-oxides of pyridylmethylpiperazine and -piperidine derivatives |
| 05/13/2009 | CN101429195A Process for producing important synthesis midbody of high purity atorvastatin |
| 05/13/2009 | CN101429194A Process for the preparation of tryptase inhibitors |
| 05/13/2009 | CN101429193A Process for producing 1-tetrahydropyran-3-methyl-5-amido indazole |
| 05/13/2009 | CN100486973C Novel benzodioxoles |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/12/2009 | US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 05/12/2009 | US7531665 Kinase inhibitors for the treatment of disease |
| 05/12/2009 | US7531655 Large conductance calcium-activated K channel opener |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531537 Benzofuran derivative |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009059304A2 Compounds for treating abnormal cellular proliferation |
| 05/07/2009 | WO2009059243A1 Treating and preventing viral infections |
| 05/07/2009 | WO2009058653A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | WO2009058300A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056632A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009010789A3 Pyrimidine derivatives 934 |
| 05/07/2009 | WO2008155081A3 Substituted aromatic heterocyclic compounds as fungicides |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 05/07/2009 | WO2007015262A3 A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 05/07/2009 | US20090118506 6,11-bridged biaryl macrolides |
| 05/07/2009 | US20090118471 Novel coumarin derivatives |
| 05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118267 Indanes |
| 05/07/2009 | US20090118259 Pharmaceutical use of substituted amides |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | CA2704529A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | CA2703876A1 Enantioselective process for preparing a substituted alkanoic acid |
| 05/07/2009 | CA2702320A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/06/2009 | EP2055698A1 Chromene compound |
| 05/06/2009 | EP2054407A2 Pyrolidine derivatives useful against diseases that depends on activity of renin |
| 05/06/2009 | EP2054406A1 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 05/06/2009 | EP2054385A2 Phenyl, pyridine and quinoline derivatives |
| 05/06/2009 | EP2054063A2 4-aminoquinazoline derivatives and methods of use thereof |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1613156B1 N-phenyl- " (4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101426780A Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |